Form 10-Q · Quarterly report
Vulcan Materials Company 10-Q, filed Jul 29, 2026
- Filed
- CIK
- 0001396009
- Accession no.
- 0001628280-26-050486
Summary
Vulcan Materials reported second-quarter 2026 total revenues of $2.16 billion, up 3% from a year earlier, with net earnings attributable to Vulcan of $323.4 million and Adjusted EBITDA down 1% to $654.0 million, and reaffirmed its full-year outlook of $2.4 billion to $2.6 billion in Adjusted EBITDA. During the quarter the company completed the previously announced divestiture of its California ready-mixed concrete operations and acquired a southern Colorado quarry and a Dallas-Fort Worth rail yard from Brannan Sand & Gravel.
Key points
- Total revenues rose $53.4 million, or 3%, to $2,155.8 million, and Aggregates segment sales rose $113.4 million, or 7%, to $1,763.0 million.
- Aggregates freight-adjusted sales price increased 3.9% to $22.97 per ton, with shipments up 1% to 59.9 million tons.
- Vulcan returned $67.5 million in dividends at $0.52 per share and $250.3 million in share repurchases at an average price of $276.69 per share.
- Asphalt mix shipments fell 12% and ready-mixed concrete shipments fell 17% from the prior-year quarter.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2 Management’s Discussion OVERVIEW We provide the basic materials for the infrastructure needed to maintain and expand the U.S. economy. We operate primarily in the U.S. and are the nation's largest supplier of construction aggregates (primarily crushed stone, sand and gravel) and a major producer of aggregates-intensive downstream products such as asphalt mix and ready-mixed concrete. Our strategy and competitive advantage are based on our strength in aggregates which are used in most types of construction and in the production of asphalt mix and ready-mixed concrete. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.